Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555983 · ClinicalTrials.gov registry record · Phase 2
Vaporized Cannabis and Spinal Cord Injury Pain
A Phase 2 study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by Barth Wilsey.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01555983: Completed Phase 2 study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by Barth Wilsey.
NCT01555983 is a Phase 2 study of Spinal Cord Injuries and Spinal Cord Diseases that has completed, run by Barth Wilsey. The registered enrollment target is 42 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01555983, a Phase 2 study of Spinal Cord Injuries and Spinal Cord Diseases, has completed, sponsored by Barth Wilsey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will demonstrate that vaporized marijuana results in antinociception when compared to placebo in subjects with spinal cord injury. To further evaluate potential benefits and side effects, the effect of different strengths of cannabis on mood, cognition, and psychomotor performance will also be measured.
Primary Outcome
Number of participants achieving a reduction of pain intensity of 30% or more, a level believed to be clinically important, was estimated for each treatment dose.
Conditions Studied
Interventions
- DRUG Vaporization of Cannabis
Study Locations (1)
California
- UC Davis CTSC Clinical Research Center , Sacramento VA Medical Center - Mather
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
What the finished NCT01555983 record still lists
NCT01555983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (31% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Vaporization of Cannabis is the first listed.
NCT01555983 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01555983 about?
NCT01555983 is a clinical study titled "Vaporized Cannabis and Spinal Cord Injury Pain". This study will demonstrate that vaporized marijuana results in antinociception when compared to placebo in subjects with spinal cord injury. To further evaluate potential benefits and side effects, the effect of different strengths of cannabis on mood, cognition, and psychomotor performance will al...
What is the current status of trial NCT01555983?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2012-07. Estimated completion is 2014-08.
What conditions does trial NCT01555983 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Diseases.
What interventions are being tested in trial NCT01555983?
The interventions under investigation include: Vaporization of Cannabis (DRUG).
Who is sponsoring clinical trial NCT01555983?
This trial is sponsored by Barth Wilsey, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01555983 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01555983's enrollment target sits among peer trials
42 70th of 202 higher than 132 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Epidural Stimulation and Resistance Training After SCI
RECRUITING · Phase 2
-
Intravesical LGG VS Saline Bladder Wash RCT
RECRUITING · Phase 2
-
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
Effects of 5HTP on the Injured Human Spinal Cord
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia